COPS4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.462600E-01
Normal-vs-Stage2
3.473600E-01
Normal-vs-Stage3
5.247200E-01
Normal-vs-Stage4
7.646200E-01
Stage1-vs-Stage2
3.646200E-01
Stage1-vs-Stage3
5.006600E-01
Stage1-vs-Stage4
4.853400E-01
Stage2-vs-Stage3
8.121000E-01
Stage2-vs-Stage4
1.285820E-01
Stage3-vs-Stage4
3.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.297600E-01
Normal-vs-AfricanAmerican
8.485800E-01
Normal-vs-Asian
6.760100E-02
Caucasian-vs-AfricanAmerican
7.782800E-01
Caucasian-vs-Asian
1.407980E-02
AfricanAmerican-vs-Asian
4.792000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.373600E-01
Normal-vs-Female
7.689800E-01
Male-vs-Female
4.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.842600E-01
Normal-vs-Age(41-60Yrs)
9.836200E-01
Normal-vs-Age(61-80Yrs)
6.113400E-01
Normal-vs-Age(81-100Yrs)
2.592000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.570200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.769200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.401400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.220100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.517050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.526960E-01
Normal-vs-Daily Drinker
1.791250E-01
Normal-vs-Weekly Drinker
2.447800E-01
Normal-vs-Occasional Drinker
7.276600E-01
Normal-vs-Social Drinker
8.833200E-01
Non Drinker-vs-Daily Drinker
4.124200E-01
Non Drinker-vs-Weekly Drinker
8.885800E-01
Non Drinker-vs-Occasional Drinker
1.916410E-02
Non Drinker-vs-Social Drinker
1.809960E-01
Daily Drinker-vs-Weekly Drinker
6.034400E-01
Daily Drinker-vs-Occasional Drinker
4.391800E-02
Daily Drinker-vs-Social Drinker
3.367800E-01
Weekly Drinker-vs-Occasional Drinker
3.499700E-02
Weekly Drinker-vs-Social Drinker
2.554400E-01
Occasional Drinker-vs-Social Drinker
3.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.742400E-01
Normal-vs-Grade 2
7.978200E-01
Normal-vs-Grade 3
7.769400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.779210E-01
Grade 1-vs-Grade 3
2.429200E-01
Grade 1-vs-Grade 4
4.742400E-01
Grade 2-vs-Grade 3
6.473200E-01
Grade 2-vs-Grade 4
7.978200E-01
Grade 3-vs-Grade 4
7.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.136200E-01
Normal-vs-NonDiabetic
6.898400E-01
Diabetic-vs-NonDiabetic
4.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.588990E-01
Normal-vs-NoPancreatitis
6.942400E-01
Pancreatitis-vs-NoPancreatitis
2.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.602000E-01
Normal-vs-N1
3.877000E-01
N0-vs-N1
7.342200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.269600E-01
Normal-vs-TP53-NonMutant
9.072600E-01
TP53-Mutant-vs-TP53-NonMutant
5.667600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
